1 Main outcomes |
4 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.1 Death at 6 to 12 months |
4 |
296 |
Risk Ratio (M‐H, Random, 95% CI) |
1.54 [0.60, 4.00] |
1.2 Graft loss (all cause) at 6 to 12 months |
4 |
296 |
Risk Ratio (M‐H, Random, 95% CI) |
0.86 [0.47, 1.59] |
1.3 Acute rejection at 6 months |
3 |
213 |
Risk Ratio (M‐H, Random, 95% CI) |
0.72 [0.48, 1.08] |
1.4 Acute rejection ≥ 1 year |
3 |
244 |
Risk Ratio (M‐H, Random, 95% CI) |
0.89 [0.42, 1.87] |
1.5 Delayed graft function |
1 |
30 |
Risk Ratio (M‐H, Random, 95% CI) |
2.0 [0.26, 15.62] |
2 Other adverse outcomes |
3 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
2.1 CMV infection |
2 |
161 |
Risk Ratio (M‐H, Random, 95% CI) |
2.28 [1.18, 4.40] |
2.2 Infection (all cause) |
3 |
213 |
Risk Ratio (M‐H, Random, 95% CI) |
1.15 [0.46, 2.89] |
2.3 NODAT |
2 |
161 |
Risk Ratio (M‐H, Random, 95% CI) |
0.57 [0.13, 2.46] |
2.4 Thrombocytopenia |
1 |
30 |
Risk Ratio (M‐H, Random, 95% CI) |
1.33 [0.45, 3.96] |
2.5 Malignancy or PTLD |
1 |
30 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3 Serum creatinine |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
3.1 6 months |
1 |
27 |
Mean Difference (IV, Random, 95% CI) |
‐5.0 [‐28.90, 18.90] |
3.2 1 year |
2 |
108 |
Mean Difference (IV, Random, 95% CI) |
‐2.89 [‐43.29, 37.52] |